All lobbying filings

KELLEY DRYE & WARREN LLP

KELLEY DRYE & WARREN LLP filed a Q1 report for PARTNERSHIP TO END HIV, AIDS & HEPATITIS on April 20, 2026, reporting $40,000 in lobbying income.

Lobbying for PARTNERSHIP TO END HIV, AIDS & HEPATITIS · Coalition of non-profit organizations supporting funding and access to HIV/AIDS treatments

All filings by KELLEY DRYE & WARREN LLP · Everything PARTNERSHIP TO END HIV, AIDS & HEPATITIS has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 20, 2026

Income

$40,000

What the client paid this registrant for the period.

Client based in

Florida

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

H.R. 7148, FY2026 Consolidated Defense, LHHSED, Nat. Sec.-State, THUD, FSGG Appropriations Act, provisions relating to funding for Ending the HIV Epidemic Initiative, Ryan White HIV/AIDS Program, CDCs National Center for HIV, Viral Hepatitis, STD, and TB Prevention, HRSA STD Clinical Services, Minority HIV/AIDS Fund; the Housing Opportunities for Persons with AIDS Program (HOPWA), and expanded access to pre-exposure prophylaxis (PrEP) medications and related support.

Bills named in this filing 1

H.R. 7148
Consolidated Appropriations Act, 2026

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.